Novo responded the same day, publicly characterizing the product as "illegal mass compounding that poses a significant risk to patient safety." On February 6, the FDA announced it would take action against companies mass-marketing unapproved compounded GLP-1 products, and HHS General Counsel stated publicly that the department had referred Hims to the DOJ for potential FDCA violations
Moreover, TCM not only exhibits pharmacological activity that stimulates hair growth but also regulates hair follicle abnormalities through multi-pathway, multi-target, and multi-channel mechanisms
The key is making each reduction intentionally, not accidentally drawing less because your vial is running low or your syringe hand was less precise that morning
Our platform is designed to make personalized, medically supervised care attainable, which is especially important when dealing with the potential GI side effects of weight loss medications
Shristi Shrestha, MD is a family physician who was raised in Kathmandu, Nepal